Stylage Full Face Rejuvenation Bundle
STYLAGE
Aesthetic / Combination Treatment BundleDermal filler & skin revitalisation bundle
Certifications
- STYLAGE range (Vivacy) is marketed as CE Marked medical devices in applicable jurisdictions — verify local conformity/certificates with the authorised distributor.
- Manufactured using Vivacy quality systems; sterile single Use packaging and traceability required for professional use.
- STYLAGE range (Vivacy) is marketed as CE Marked medical devices in applicable jurisdictions — verify local conformity/certificates with the authorised distributor.
- Manufactured using Vivacy quality systems; sterile single Use packaging and traceability required for professional use.
Dermal filler & skin revitalisation bundle
Description
Curated professional bundle combining volumising and hydrating STYLAGE products to address facial volume loss and skin quality. The bundle pairs deep volumising fillers (2 × STYLAGE Bi-Soft XL Lidocaine and 1 × STYLAGE XXL Mepivacaine) for lift and contour with intensive skin-revitalising gels (2 × STYLAGE Bi-Soft HydroMax) to improve hydration and dermal elasticity. Intended for use by trained aesthetic practitioners as a comprehensive course to restore structure and skin quality across multiple facial areas.
Bnefits
- Combines volumisation and skin hydration for a comprehensive full-face rejuvenation approach
- Volumising components (Bi-Soft XL and XXL Mepivacaine) provide projection and contouring for cheeks, jawline and chin
- Hydromax components (Bi-Soft HydroMax) improve dermal hydration, elasticity and skin texture
- Cost-effective bundled supply for practitioners planning multi-product treatment protocols
- Includes products formulated with Vivacy IPN-Like crosslinked HA technology and antioxidant excipients (mannitol or sorbitol) for gel stability
Indications
- Restoration of facial volume and structural contouring (cheeks, chin, jawline, mandibular angle)
- Improvement of skin hydration, elasticity and overall dermal quality for face, neck, décolleté and hands
- Combination use in staged treatment protocols to address both volume loss and skin quality
Composition
- STYLAGE Bi-Soft XL Lidocaine: cross-linked hyaluronic acid (HA) gel (Vivacy IPN-Like technology), mannitol antioxidant, lidocaine (in lidocaine variant); typical HA concentrations per product labeling (refer to IFU for exact mg/ml).
- STYLAGE XXL Mepivacaine: cross-linked HA gel with mannitol and mepivacaine (local anaesthetic); reported strength ~21 mg/g HA and 3 mg/ml mepivacaine in distributor product specs.
- STYLAGE Bi-Soft HydroMax: lightly cross-linked HA plus Sorbitol (Skin3 Complex) designed for hydration; typical concentration ~12.5 mg/ml (refer to product IFU for exact values).
Formulation
- Sterile, single-use pre-filled HA syringes in various rheology profiles (Bi-Soft technology) tailored for volumising (XL/XXL) or skin boosting (HydroMax).
- Local anaesthetic variants include lidocaine or mepivacaine depending on the product presentation.
Packaging
- Bundle contents (as listed by distributor example): 2 × STYLAGE Bi-Soft XL Lidocaine (2 × 1 ml syringes), 1 × STYLAGE XXL Mepivacaine (2 × 1 ml syringes), 2 × STYLAGE Bi-Soft HydroMax (1 ml syringes). Exact needle/cannula inclusions and box contents vary by distributor and market.
Usage
- For professional use only — inject by certified medical practitioners experienced in dermal filler procedures.
- Follow Vivacy Instructions for Use (IFU) for injection depth, volumes per session, recommended techniques for each product and area, and post-procedure care.
- Perform full patient assessment, allergy/contraindication screening and obtain informed consent prior to treatment.
- Maintain aseptic technique and be prepared to manage complications (have hyaluronidase and emergency protocols available).
Contraindications
- Hypersensitivity to hyaluronic acid, local anaesthetics (lidocaine or mepivacaine where present), or any component of the formulations.
- Active infection or inflammation at intended injection sites.
- Pregnancy and breastfeeding (use not recommended — follow local labelling).
- Patients with severe allergies or history of anaphylaxis should be assessed carefully before treatment.
Adverse Effects
- Common, usually transient: injection-site reactions — redness, swelling, bruising, pain, tenderness, lumps/bumps.
- Uncommon/rare: infection, persistent nodules or granulomatous reaction, vascular occlusion (may lead to skin necrosis), and very rare ocular complications if inadvertent intra-arterial injection occurs.
- Follow manufacturer IFU and clinical protocols for recognition and management of complications (e.g., hyaluronidase administration for vascular compromise).
Storage Conditions
- Store products as per each product IFU — typically controlled ambient conditions (commonly 2 °C to 25 °C); do not freeze; protect from excessive heat and direct sunlight; check expiry dates prior to use.
Duration
Durability varies by product and patient factors: volumising fillers (XL/XXL) commonly claim extended longevity (often up to 12\u201318 months depending on area and product), Hydromax effects on hydration are typically shorter-term and may be sustained with repeat treatments; refer to product IFUs for detail.
Onset
Immediate visual improvement is typically observed after injection; final settled result assessed after transient post-injection swelling subsides (hours to days).
